Today: 25 January 2026
Subscribe
Browse Category

Stock Market News 20 December 2025

Arista Networks (ANET) Stock: Latest News, Analyst Forecasts, and Key Catalysts as of Dec. 20, 2025

Arista Networks (ANET) Stock: Latest News, Analyst Forecasts, and Key Catalysts as of Dec. 20, 2025

Arista Networks, Inc. (NYSE: ANET) heads into the weekend with its stock back in motion after a choppy December: shares finished the latest trading session (Friday, Dec. 19, 2025) at $131.12, up 5.22% on the day, after ranging roughly from the mid‑$125s to low‑$132s intraday. Investing Zooming out, ANET is still meaningfully below its 52‑week high of $164.94 (set on…
20 December 2025
····
Virgin Galactic (SPCE) Stock News and Forecast — Dec. 20, 2025: Debt “Reset,” Analyst Targets, and the Long Road to Delta Flights

Virgin Galactic (SPCE) Stock News and Forecast — Dec. 20, 2025: Debt “Reset,” Analyst Targets, and the Long Road to Delta Flights

Virgin Galactic Holdings, Inc. (NYSE: SPCE) is ending the week with a familiar combo for space-tourism investors: a sharp move in the share price, a capital-structure overhaul, and a business timeline that still points to 2026 as the real inflection year. On Friday, December 19, SPCE rose 6.71% to close at $3.50, marking a fourth straight day of gains. Volume…
20 December 2025
···
Rocket Lab Stock (RKLB) Hits a Record High After a Landmark $816M Missile-Tracking Satellite Deal: News, Forecasts, and What’s Next (Dec. 20, 2025)

Rocket Lab Stock (RKLB) Hits a Record High After a Landmark $816M Missile-Tracking Satellite Deal: News, Forecasts, and What’s Next (Dec. 20, 2025)

December 20, 2025 — Rocket Lab Corporation (NASDAQ: RKLB) is ending the week with the kind of headline every growth stock dreams about: a record close, a major U.S. national security contract, and renewed investor focus on the company’s longer-term “make-or-break” catalyst—Neutron, its next-generation medium-lift rocket. Shares surged into Friday’s close (the last trading session before today’s weekend), closing at…
20 December 2025
····
Luminar Technologies Stock (LAZR) in Focus: Chapter 11, Nasdaq Delisting, and Analyst Forecasts as Volatility Surges (Dec. 20, 2025)

Luminar Technologies Stock (LAZR) in Focus: Chapter 11, Nasdaq Delisting, and Analyst Forecasts as Volatility Surges (Dec. 20, 2025)

December 20, 2025 — Luminar Technologies stock (ticker: LAZR) has entered one of the most extreme—and most misunderstood—phases a public company can experience: trading during an active Chapter 11 bankruptcy process while facing imminent Nasdaq delisting. At the last close on Friday, December 19, 2025, LAZR finished around $0.6044 after a massive one-day move and extraordinary trading volume (hundreds of…
20 December 2025
····
3i Group plc Stock (LSE:III) News, Forecasts and Analysis as of 20 December 2025: Action Wobbles in France, Analysts Stay (Mostly) Bullish

3i Group plc Stock (LSE:III) News, Forecasts and Analysis as of 20 December 2025: Action Wobbles in France, Analysts Stay (Mostly) Bullish

Dec. 20, 2025 — London. 3i Group plc (LSE:III) ends the week in a familiar place for long-time shareholders: priced like a premium product, but currently being treated like a discounted one. After a bruising sell-off following November’s half-year update, the stock has steadied around the low-3,200s pence—yet it’s still roughly 27% below its 52‑week peak set in late October.…
20 December 2025
····
National Grid plc Stock (NG.L): Share Price, RIIO‑T3 Decision, Sea Link Contracts and Analyst Forecasts as of 20 December 2025

National Grid plc Stock (NG.L): Share Price, RIIO‑T3 Decision, Sea Link Contracts and Analyst Forecasts as of 20 December 2025

National Grid plc stock is heading into the end of 2025 with investors focused on a single, very modern problem: electrification is accelerating faster than grid infrastructure can comfortably keep up. For a regulated utility, that can be a gift (predictable, funded growth) or a headache (political scrutiny, bill impacts, execution risk). Right now, the market is weighing both. As…
20 December 2025
····
Rio Tinto (RIO.L, NYSE: RIO) Stock: Latest News, Forecasts, and Analyst Outlook as of Dec. 20, 2025

Rio Tinto (RIO.L, NYSE: RIO) Stock: Latest News, Forecasts, and Analyst Outlook as of Dec. 20, 2025

December 20, 2025 — Rio Tinto plc stock heads into the weekend with a lot of narrative gravity: a new CEO’s strategy reboot, fresh spending on long-life iron ore supply, an Australian government move to protect a key aluminium asset, and a legal overhang tied to sanctions-era fallout. If you’re tracking Rio Tinto share price moves, this week has been…
20 December 2025
····
Lloyds Banking Group (LLOY) Share Price Near 52-Week High: Latest News, Forecasts and 2026 Outlook (20 Dec 2025)

Lloyds Banking Group (LLOY) Share Price Near 52-Week High: Latest News, Forecasts and 2026 Outlook (20 Dec 2025)

As of Saturday, 20 December 2025, Lloyds Banking Group plc (LSE: LLOY) is closing out the year with its share price pressing up against the top of its recent range—after a powerful 12-month run that has put UK bank stocks back on a lot of watchlists. The last market close (Friday, 19 December) puts Lloyds shares at 97.42p, with heavy…
20 December 2025
···
Standard Chartered PLC Stock (LSE: STAN) Near 52-Week High on Buybacks and Upgrades—But Regulators and Fraud Probe Add New Risk

Standard Chartered PLC Stock (LSE: STAN) Near 52-Week High on Buybacks and Upgrades—But Regulators and Fraud Probe Add New Risk

LONDON — December 20, 2025 — Standard Chartered PLC stock has spent December doing what markets love most: rising steadily, flirting with fresh highs, and giving analysts something new to argue about. The shares (ticker STAN on the London Stock Exchange) were last indicated around 1,788.50p as of December 20 (reflecting the latest available pricing after Friday’s close), putting the…
20 December 2025
····
GSK plc Stock News and Forecast (Dec. 20, 2025): TrumpRx Pricing Deal, Exdensur FDA Approval, Buybacks, and Analyst Targets

GSK plc Stock News and Forecast (Dec. 20, 2025): TrumpRx Pricing Deal, Exdensur FDA Approval, Buybacks, and Analyst Targets

GSK plc (LSE: GSK; NYSE: GSK) heads into the weekend with a rare “everything-bagel” mix of catalysts: a new U.S. drug-pricing agreement tied to tariff relief, a fresh FDA approval that could reshape severe-asthma dosing schedules, expanding vaccine indications in Europe, and a steady drumbeat of buybacks. For investors tracking GSK stock, the headline isn’t just one event—it’s the way…
20 December 2025
····
Shell Plc Stock (SHEL) News, Forecasts and Analysis for Dec. 20, 2025: Buybacks, LNG Outlook and Project Pipeline Drive the Narrative

Shell Plc Stock (SHEL) News, Forecasts and Analysis for Dec. 20, 2025: Buybacks, LNG Outlook and Project Pipeline Drive the Narrative

Shell Plc stock (ticker: SHEL) heads into the final stretch of 2025 with investors weighing two forces that often pull in opposite directions: near-term cash returns (dividends and aggressive buybacks) versus longer-term questions about production depth, portfolio reshaping, and execution risk across a sprawling global footprint. On the surface, Shell’s equity story still looks like the classic “Big Oil with…
20 December 2025
····
HSBC Holdings Plc Stock: Hang Seng Buyout Momentum, Analyst Upgrades, and the 2026 Outlook (Dec. 20, 2025)

HSBC Holdings Plc Stock: Hang Seng Buyout Momentum, Analyst Upgrades, and the 2026 Outlook (Dec. 20, 2025)

HSBC Holdings Plc stock is finishing the year with a distinctly “big-bank, big-decisions” vibe: a proposed take-private of Hang Seng Bank is moving into its next formal stage, a potential legal settlement in France is back on investors’ radar, and analysts are actively recalibrating what “normal” earnings look like as rate cuts spread across major economies. As of late Friday…
20 December 2025
····
1 … 835 836 837 838 839 … 1,613

Stock Market Today

  • Marriott International Valuation Assessment After Recent Share Gains
    January 25, 2026, 1:42 PM EST. Marriott International (MAR) shares closed at $319.70, up 17.88% over 90 days and 13.63% in one year, reflecting strong longer-term momentum despite recent cooling. The stock currently trades above its $301.76 estimated fair value, suggesting it may be overvalued. Analysts project a steep 63.3% annual revenue growth over three years, with valuations based on an 8.85% discount rate and elevated future price-to-earnings ratios. Investors should weigh these optimistic assumptions against risks like increased technology spending and softer revenue per available room (RevPAR) in key regions. Marriott's valuation remains intertwined with its growth trajectory and margin outlook, prompting cautious investor consideration amid the travel sector's evolving dynamics.
Go toTop